Is an Automatic Pump Suspension Feature Safe for Children with Type 1 Diabetes? An Exploratory Analysis with a Closed-Loop System

被引:24
作者
Cengiz, Eda [1 ]
Swan, Karena L. [1 ]
Tamborlane, William V. [1 ]
Steil, Garry M. [2 ]
Steffen, Amy T. [1 ]
Weinzimer, Stuart A. [1 ]
机构
[1] Yale Univ, Sch Med, Sect Pediat Endocrinol, Dept Pediat, New Haven, CT 06520 USA
[2] Joslin Diabet Ctr, Sect Islet Cell Transplantat & Cell Biol, Boston, MA 02215 USA
关键词
INSULIN DELIVERY;
D O I
10.1089/dia.2008.0102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: It has been proposed that the first step towards a closed-loop artificial pancreas might be to use a continuous glucose sensor to automatically suspend the basal insulin delivery based on projected low sensor glucose values. Methods: We reviewed our recent experience with an artificial pancreas system, utilizing a proportional-integrative-derivative (PID) algorithm, in 17 adolescents with type 1 diabetes (T1D) to assess the safety and efficacy of this maneuver. Results: During 34 h of closed-loop automated insulin delivery, 18 pump suspensions >= 60 min (90 +/- 18 min) occurred in eight subjects. Sensor glucose levels fell from 159 +/- 42mg/dL to a nadir of 72 +/- 13mg/dL. Corresponding plasma glucose levels fell from 168 +/- 51 to 72 +/- 16mg/dL, with values <60mg/dL recorded in only four of the 18 events. Conclusions: These data suggest that automatic pump suspension using the PID algorithm may be an effective means to prevent hypoglycemia in youth with T1D.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 11 条
[1]   Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM [J].
Attia, N ;
Jones, TW ;
Holcombe, J ;
Tamborlane, WV .
DIABETES CARE, 1998, 21 (05) :817-821
[2]  
Bequette B Wayne, 2005, Diabetes Technol Ther, V7, P28, DOI 10.1089/dia.2005.7.28
[3]  
Buckingham B, 2008, DIABETES, V57, pA66
[4]   Continuous glucose monitoring and closed-loop systems [J].
Hovorka, R .
DIABETIC MEDICINE, 2006, 23 (01) :1-12
[5]  
Hovorka Roman, 2004, Diabetes Technol Ther, V6, P307, DOI 10.1089/152091504774197990
[6]   Inflammatory markers and diabetic retinopathy in type 1 diabetes [J].
Izuora, KE ;
Chase, HP ;
Jackson, WE ;
Coll, JR ;
Osberg, IM ;
Gottlieb, PA ;
Rewers, MJ ;
Garg, SK .
DIABETES CARE, 2005, 28 (03) :714-715
[7]   Feasibility of automating insulin delivery for the treatment of type 1 diabetes [J].
Steil, Garry M. ;
Rebrin, Kerstin ;
Darwin, Christine ;
Hariri, Farzam ;
Saad, Mohammed F. .
DIABETES, 2006, 55 (12) :3344-3350
[8]  
Steil Garry M, 2003, Diabetes Technol Ther, V5, P953, DOI 10.1089/152091503322640999
[9]   Closed-loop insulin delivery - the path to physiological glucose control [J].
Steil, GM ;
Panteleon, AE ;
Rebrin, K .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (02) :125-144
[10]   Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes [J].
Swan, Karena L. ;
Weinzimer, Stuart A. ;
Dziura, James D. ;
Steil, Garry M. ;
Voskanyan, Gayane R. ;
Steffen, Amy T. ;
Martin, Melody L. ;
Tamborlane, William V. .
DIABETES CARE, 2008, 31 (01) :44-46